Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 4/20 | 0.61 |
| ▸ | P2RY1 | P47900 | 4/20 | 0.61 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.61 |
| ▸ | SRC | P12931 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.61 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.61 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.61 |
| ▸ | LDHA | P00338 | 1/20 | 0.61 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.61 |
| ▸ | FBP1 | P09467 | 1/20 | 0.61 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.61 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.61 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.61 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.61 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.61 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.61 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.61 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27779375 | 1.00 | AHCY (0.61) | AHCYP2RY1P2RY2SRCSMN1; SMN2 | |
| SCHEMBL28192648 | 0.99 | AHCY (0.60) | AHCYP2RY1P2RY2SRCSMN1; SMN2 | |
| SCHEMBL8836012 | 0.89 | AHCY (0.59) | AHCYP2RY1P2RY2SRCSMN1; SMN2 | |
| SCHEMBL8835991 | 0.89 | AHCY (0.59) | AHCYP2RY1P2RY2SRCSMN1; SMN2 | |
| SCHEMBL1969793 | 0.89 | P2RY2 (0.63) | AHCYP2RY1P2RY2SRCSMN1; SMN2 | |
| SCHEMBL27938581 | 0.88 | PRMT5 (0.49) | AHCYP2RY1P2RY2SRCSMN1; SMN2 | |
| SCHEMBL27938577 | 0.88 | PRMT5 (0.49) | AHCYP2RY1P2RY2SRCSMN1; SMN2 | |
| SCHEMBL397800 | 0.87 | AHCY (0.68) | AHCYSMN1; SMN2ADORA1HSP90B1HIF1A | |
| SCHEMBL31680251 | 0.87 | AHCY (0.68) | AHCYSMN1; SMN2ADORA1HSP90B1HIF1A | |
| SCHEMBL28624001 | 0.87 | PRMT5 (0.48) | AHCYP2RY1P2RY2SRCSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112625995-B | Method for producing PAPS by whole cell catalysis | 江南大学 | 2023-07-04 | — | — | CN | claimed |
| CN-116393108-A | Super-hydrophilic flower-like boric acid affinity material and preparation method and application thereof | 福州大学 | 2023-07-07 | — | — | CN | disclosed |
| CN-112625995-B | Method for producing PAPS by whole cell catalysis | 江南大学 | 2023-07-04 | — | — | CN | disclosed |
| CN-109936983-A | For enhancing the new compositions of flavor | 国际香料和香精公司 | 2019-06-25 | — | — | CN | disclosed |
| CN-103338775-B | Methods of using human milk oligosaccharides to reduce the incidence of necrotizing enterocolitis in infants, toddlers, or children | ABBOTT LABORATORIES (US) | 2016-11-30 | — | — | CN | disclosed |
| CN-106011310-A | Method for amplifying and/or detecting nucleic acids, kits and uses of said method | 生物梅里埃公司 | 2016-10-12 | — | — | CN | disclosed |
| CN-105849248-A | Novel strain of bifidobacterium animalis subsp. lactis cect 8145 and use thereof for the treatment and/or prevention of excess weight and obesity and associated diseases | 比奥波利斯有限公司 | 2016-08-10 | — | — | CN | disclosed |
| CN-105007758-A | Low-buffer nutritional composition and uses thereof | MJN US HOLDINGS LLC | 2015-10-28 | — | — | CN | disclosed |
| CN-104844687-A | Alkylamine-substituted dicyanopyridine and amino acid ester prodrugs thereof | BAYER IP GMBH | 2015-08-19 | — | — | CN | disclosed |
| CN-104561239-A | ATP (adenosine triphosphate) detection system | SHANGHAI MANYI TECHNOLOGY CO LTD | 2015-04-29 | — | — | CN | disclosed |
| CN-104126749-A | Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk | NESTEC SA | 2014-11-05 | — | — | CN | disclosed |
| CN-103929980-A | Infant formula with high SN-2 palmitate and oligofructose | NESTEC SA | 2014-07-16 | — | — | CN | disclosed |
| CN-103338775-A | Methods of using human milk oligosaccharides to reduce the incidence of necrotizing enterocolitis in infants, toddlers, or children | ABBOTT LAB | 2013-10-02 | — | — | CN | disclosed |
| CN-101654712-A | Method for testing sequence of nucleic acid single molecule | UNIV SHANGHAI JIAOTONG | 2010-02-24 | — | — | CN | disclosed |
| US-20090274686-A1 | NUCLEOSIDE PHOSPHONATE DERIVATIVES | ENANTA PHARMACEUTICALS, INC. | 2009-11-05 | — | — | US | disclosed |
| US-20090186358-A1 | Pathway Analysis of Cell Culture Phenotypes and Uses Thereof | WYETH (US) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274686-A1 | NUCLEOSIDE PHOSPHONATE DERIVATIVES | ENTPD5, PNP, TYMP | AHCY 379/4885P2RY1 251/4885P2RY2 534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.